Sessions*

Oral Concurrent Session 1
4-year Follow-Up Study of Children Exposed to 17P In Utero
- Paul Meis, MD, Professor of Ob/Gyn, Wake Forest University, Winston-Salem, NC
- Allison Northen, RN, University of Alabama at Birmingham, Birmingham, AL, USA

Web material related to this session supported by an unrestricted educational grant from Cytyc

Poster Session V
Negative fFN, Who is Still Managed Aggressively and Does it Help?
- Linda Pelaez, MD, Weill Medical College, Cornell University, New York, NY, USA
Download poster in PDF format

Web material related to this session supported by an unrestricted educational grant from Cytyc

A New Patient Safety Initiative - NTQR
- Lawrence Platt, MD, Director, Center For Fetal Medicine & Woman's Ultrasound in Los Angeles

Professor of Ob-Gyn at UCLA, Los Angeles, CA, USA

Web material related to this session supported by an unrestricted educational grant from GE Healthcare

Poster Session I
AmniSure® for the Diagnosis of Ruptured Membranes
- Errol R. Norwitz, MD, PhD, Yale University School of Medicine, New Haven, CT, USA

Web material related to this session supported by an unrestricted educational grant from AmniSure International LLC

Oral Plenary Session 1
Study Results of the Randomized Controlled Trial of 17-OHCP for the Prevention of Preterm Birth in Twins
- Steve N. Caritis, MD, Magee-Womens Hospital, University of Pittsburgh, Pittsburgh, PA, USA

Oral Plenary Session I
Antenatal Steroids
- Ronald Wapner, MD, Director, Division of Maternal Fetal Medicine, New York-Presbyterian Hospital, New York, NY, USA

Oral Concurrent Session 1
Proteomics of the Amniotic Fluid to Predict Preterm Birth
- Catalin S. Buhimschi, MD, Assistant Professor, Director Perinatal Research, Yale University School of Medicine, New Haven, CT, USA

- Irina Buhimschi, MD, Assistant Professor, Director Perinatal Research, Yale University School of Medicine, New Haven, CT, USA

Oral Concurrent Session 2
Calcium Binding Protein S100B as a Marker in Perinatology
- Lara A. Friel, MD, PhD, Perinatology Research Branch of the NICHD, Wayne State University, Detroit, MI, USA

Oral Concurrent Session 2
Fetal Congenital Heart Block
- Joshua Copel, MD, Professor & Vice Chair, Obstetrics; Director of the Yale Fetal Cardiovascular Center, New Haven, CT, USA

Poster Session I
Elevated LDH Levels in PPROM
- Lissa Magloire, MD, Yale University School of Medicine, New Haven CT, USA

Oral Plenary Session II
The Proper Timing of Prophylactic Antibiotics for Caesarian Section
- Scott A. Sullivan, MD, MSCR, FACOG, Medical University of South Carolina, Charleston, SC, USA

Plenary Session II
Placental Gene Transfer of IGF-1 Corrects Fetal Growth Restriction
- Ursula Harkness, MD, Mountain Area Health Education Center, Ashville, NC, USA

Oral Concurrent Session 4
Twin to Twin Transfusion Syndrome
- Timothy M. Crombleholme, MD, FACS, FAAP, Fetal Care Center of Cincinnati Children's Hospital, Cincinnati, OH, USA

Oral Concurrent Session 4
Assisted Reproductive Technology and the Risk of Birth Defects
- Darine El-Chaâr, MD, University of Ottowa - The Ottawa Hospital, Ottawa, ON, Canada

Oral Concurrent Session 5
Induction of Labor
- Christian Pettker, MD, Yale University School of Medicine, New Haven CT, USA

Poster Session III
Challenging the TH1/TH2 Paradigm of Pregnancy
- Donna Neale, MD, Johns Hopkins University, Baltimore, MD, USA

Poster Session V
Advanced Maternal Age and Risk of Intrauterine Fetal Death
- Mert Ozan Bahtiyar, MD, Yale University School of Medicine, New Haven CT, USA

First Trimester Miscarriage
- Errol R. Norwitz, MD, PhD, Yale University School of Medicine, New Haven CT, USA

*The sponsors for these sessions have had no input in the production or scientific content of the presented abstracts